Skip to content
Screener

Pacira BioSciences, Inc. PCRX Business Segments — Other

Similar metrics at other companies

BGSF logo
BGSFProperty Management — Other
$476K-73.6%
Ouster logo
OUSTReportable Segment — Other costs
$3.55M+94.6%
IPG Photonics logo
IPGPReportable Segment — Other manufacturing expenses
$36.84M+19.3%
Noodles & Company logo
NDLSReportable Segment — Other restaurant operating costs
$25.37M+3.9%
LPR
LPROReportable Segment — Other cost of services
$1.28M-22.1%
First Watch Restaurant Group, Inc. logo
FWRGReportable Segment — Other restaurant operating expenses
$51.9M+17.3%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-11.9%
Enterprise value$1.26B+6.9%
P/E194.1×—
P/S1.4×-0.2×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherCostOfOperatingRevenue.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
Line itemThree Months Ended March 31, 20262025
Amortization of acquired intangible assets14,32214,322
Changes in the fair value of contingent consideration(2,277)(2,675)
Legal settlement—7,000
Other (2)8801,862
Total operating expenses170,474166,933
Total other (expense) income, net(1,904)6,716
Income before income taxes4,9988,706
Income tax expense(2,082)(3,894)

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s business segments — other?
Pacira BioSciences, Inc. (PCRX) reported business segments — other of $880K in Q1 2026.
How has Pacira BioSciences, Inc.'s business segments — other changed year-over-year?
Pacira BioSciences, Inc.'s business segments — other decreased by 52.7% year-over-year, from $1.86M to $880K.
What is the long-term trend for Pacira BioSciences, Inc.'s business segments — other?
Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — other has grown at a -9.4% compound annual growth rate (CAGR), from $22.17M to $16.51M.
What does business segments — other mean?
Represents miscellaneous operating expenses or income items within the reportable segment that do not fit into standard cost categories. Monitoring this helps identify non-core operational fluctuations that may impact the segment's overall financial performance.

Ask your AI about Pacira BioSciences, Inc.'s business segments — other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude